1/24
Vocabulary and conceptual flashcards covering emesis and antiemetic therapy, laxatives and constipation management, antidiarrheals, receptor pathways, and adverse effect profiles.
Chemoreceptor Trigger Zone (CTZ)
An area located near the medulla exposed to blood and cerebrospinal fluid that detects emetic stimuli such as toxins, drugs, Levodopa, and Levodopa derivatives; emesis signaling is mediated via receptors including dopamine (D2), serotonin (5-HT3), histamine (H1), acetylcholine, and neurokinin-1 (NK1).
Vomiting Center
A coordinate nucleus located in the medulla (nucleus of tractus solitarius) that initiates the motor efferent reflex of vomiting in response to sensory inputs from the CTZ, vestibular system, cortex (pain, emotion), or peripheral triggers such as odor, smell, taste, and gastric mucosal irritation.
Dimenhydrinate
An H1 receptor antagonist prototype that inhibits vestibular stimulation in the middle ear to treat motion sickness and post-operative nausea/vomiting; carries anticholinergic side effects and is contraindicated in narrow-angle glaucoma.

Narrow-Angle Glaucoma
An ocular disorder characterized by blockage of fluid drainage at the iridocorneal angle; medications with anticholinergic properties (such as H1 blockers, scopolamine, and phenothiazines) are contraindicated because pupil dilation further occludes drainage and elevates intraocular pressure.
Scopolamine
An anticholinergic prototype that blocks muscarinic (M1) receptors and inhibits cholinergic transmission from the vestibular nuclei to the vomiting center; used for motion sickness, post-operative emesis, and palliative reduction of end-of-life "death rattle" respiratory secretions.
Anticholinergic Side Effects
Adverse effects resulting from muscarinic receptor antagonism, presenting clinically as urinary retention, decreased sweating (feeling hot), dry mouth and constipation, tachycardia, blurred vision with dry eyes, and CNS manifestations including sedation, dizziness, confusion, or hallucinations.

Metoclopramide
A prokinetic and antiemetic prototype that blocks dopamine (D2) receptors in the CTZ; used for post-operative emesis and emesis induced by chemotherapy, radiation, or anesthetics; adverse effects include anticholinergic manifestations, extrapyramidal symptoms (EPS), and tardive dyskinesia.
Prochlorperazine
A dopamine (D2) antagonist prototype acting in the CTZ used to treat nausea, vomiting, and psychotic disorders; adverse effects include drowsiness, dizziness, hypotension, anticholinergic effects, and extrapyramidal symptoms (EPS) including dystonia, akathisia, and Parkinsonism.
Ondansetron
A serotonin (5-HT3) receptor antagonist that prevents emesis by blocking peripheral vagal receptors in the GI tract and central receptors in the CTZ; most effective for chemotherapy-related and surgical emesis, lacking extrapyramidal symptoms but carrying risk for QT-interval prolongation.

Torsade de Pointes
A specific form of polymorphic ventricular tachycardia displaying twisting of the QRS complexes around the isoelectric baseline; triggered by drugs causing prolonged QT intervals, such as serotonin (5-HT3) antagonists and high-dose loperamide.
Methylprednisolone
A glucocorticoid antiemetic that reduces emetic signaling by suppressing inflammation triggered by afferent parasympathetic stimulation to the vomiting center; adverse effects include hyperglycemia, hypokalemia, hypernatremia, and hypertension.
Aprepitant
A neurokinin-1 (NK1) receptor antagonist prototype that blocks substance P from binding to central receptors; specifically used for delayed chemotherapy-induced emesis, often co-administered with 5-HT3 antagonists and corticosteroids.
Dronabinol
A prescription cannabinoid prototype used for chemotherapy-induced nausea and vomiting as well as an appetite stimulant for AIDS-related anorexia; adverse effects include euphoria, depersonalization, confusion, and psychosis, making it contraindicated in psychiatric disorders.
Psyllium
A bulk-forming laxative prototype that increases fecal mass via fiber supplementation; must be stirred in 8oz of water or juice, ingested immediately, and followed by additional fluid to avoid esophageal obstruction or solidification into "cement."
Magnesium Citrate
An osmotic saline laxative prototype that rapidly pulls fluid into the intestinal lumen to induce bulk and bowel evacuation for diagnostic procedures; contraindicated in chronic kidney disease and heart failure due to risk of severe hypermagnesemia.
Lactulose
An osmotic sugar laxative prototype that draws water into the stool and traps ammonia in the colon for excretion; clinical goal in hepatic encephalopathy from liver cirrhosis is achieving 2–3 soft bowel movements per day to lower serum ammonia.
Bisacodyl
A stimulant (contact) laxative prototype available in tablet or suppository form that directly stimulates sensory nerve endings in the intestinal mucosa to increase peristalsis; excessive use causes potassium (K+) and calcium (Ca2+) imbalance and bowel dependency.
Senna
A stimulant laxative that acts as a local colon irritant to promote peristalsis and fluid accumulation; typically administered at bedtime, not recommended for pregnancy or chronic use, and may cause benign yellow-green discoloration of urine and feces.
Docusate Sodium
An emollient laxative (stool softener) prototype that decreases surface tension at the oil-water interface to facilitate fluid entry into the stool; used post-operatively, after myocardial infarction (MI), and during pregnancy to prevent Valsalva straining.
Linaclotide
A guanylate cyclase-C agonist prototype that stimulates intracellular cGMP production, increasing chloride and bicarbonate secretion into the lumen to accelerate transit; carries a Black Box Warning against use in children under age 6 due to risk of fatal dehydration.
Methylnaltrexone Bromide
A peripherally acting μ-opioid receptor antagonist administered subcutaneously that relieves opioid-induced constipation by blocking GI receptors without crossing the blood-brain barrier, preserving central analgesia.

Bristol Stool Chart
A diagnostic scale classifying human feces into seven categories: Type 1 (hard separate pellets) and Type 2 (lumpy sausage) indicating constipation; Types 3 and 4 representing ideal, normal stools; and Types 5, 6, and 7 representing progressive softness toward liquid diarrhea.
Diphenoxylate with Atropine
An antidiarrheal combination agent where diphenoxylate decreases intestinal motility and peristalsis, while subtherapeutic atropine prevents recreational abuse and reduces mucosal hypersecretion and cramping; contraindicated in narrow-angle glaucoma.
Loperamide
An over-the-counter antidiarrheal agent that decreases intestinal motility, fluid, and electrolyte loss without crossing the blood-brain barrier; contraindicated in bloody diarrhea or fever due to infection retention risks, and linked to QT prolongation at supratherapeutic doses.
Bismuth Subsalicylate
An over-the-counter adsorbent antidiarrheal that coats GI mucosal walls to bind bacterial toxins and treat traveler's diarrhea; causes harmless grayish-black stool discoloration and is contraindicated in pediatric patients with viral illnesses due to risk of Reye's syndrome.